180 related articles for article (PubMed ID: 16208731)
1. Preparation of cyclo-phen-type ligands: chelators of metal ions as potential therapeutic agents in the treatment of neurodegenerative diseases.
Boldron C; Van der Auwera I; Deraeve C; Gornitzka H; Wera S; Pitié M; Van Leuven F; Meunier B
Chembiochem; 2005 Nov; 6(11):1976-80. PubMed ID: 16208731
[No Abstract] [Full Text] [Related]
2. Multi-target-directed ligands to combat neurodegenerative diseases.
Cavalli A; Bolognesi ML; Minarini A; Rosini M; Tumiatti V; Recanatini M; Melchiorre C
J Med Chem; 2008 Feb; 51(3):347-72. PubMed ID: 18181565
[No Abstract] [Full Text] [Related]
3. Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease.
Rodríguez-Rodríguez C; Sánchez de Groot N; Rimola A; Alvarez-Larena A; Lloveras V; Vidal-Gancedo J; Ventura S; Vendrell J; Sodupe M; González-Duarte P
J Am Chem Soc; 2009 Feb; 131(4):1436-51. PubMed ID: 19133767
[TBL] [Abstract][Full Text] [Related]
4. Metal ions, Alzheimer's disease and chelation therapy.
Budimir A
Acta Pharm; 2011 Mar; 61(1):1-14. PubMed ID: 21406339
[TBL] [Abstract][Full Text] [Related]
5. Complexes of greatly enhanced thermodynamic stability and metal ion size-based selectivity, formed by the highly preorganized non-macrocyclic ligand 1,10-phenanthroline-2,9-dicarboxylic acid. A thermodynamic and crystallographic study.
Melton DL; Vanderveer DG; Hancock RD
Inorg Chem; 2006 Nov; 45(23):9306-14. PubMed ID: 17083230
[TBL] [Abstract][Full Text] [Related]
6. Properties of a new 4-imidazolyl derivative of a 14-membered tetraazamacrocyclic chelating agent.
Nunes RM; Delgado R; Cabral MF; Costa J; Brandão P; Félix V; Goodfellow BJ
Dalton Trans; 2007 Oct; (40):4536-45. PubMed ID: 17928911
[TBL] [Abstract][Full Text] [Related]
7. A simple, one-step procedure for the formation of chiral metallamacrocycles.
Campbell K; Johnson CA; McDonald R; Ferguson MJ; Haley MM; Tykwinski RR
Angew Chem Int Ed Engl; 2004 Nov; 43(44):5967-71. PubMed ID: 15547907
[No Abstract] [Full Text] [Related]
8. Auto-assembling of ditopic macrocyclic lanthanide chelates with transition-metal ions. Rigid multimetallic high relaxivity contrast agents for magnetic resonance imaging.
Paris J; Gameiro C; Humblet V; Mohapatra PK; Jacques V; Desreux JF
Inorg Chem; 2006 Jun; 45(13):5092-102. PubMed ID: 16780331
[TBL] [Abstract][Full Text] [Related]
9. Reorganizing metals: the use of chelating compounds as potential therapies for metal-related neurodegenerative disease.
Badrick AC; Jones CE
Curr Top Med Chem; 2011; 11(5):543-52. PubMed ID: 21189128
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization, and metal coordinating ability of multifunctional carbohydrate-containing compounds for Alzheimer's therapy.
Storr T; Merkel M; Song-Zhao GX; Scott LE; Green DE; Bowen ML; Thompson KH; Patrick BO; Schugar HJ; Orvig C
J Am Chem Soc; 2007 Jun; 129(23):7453-63. PubMed ID: 17511455
[TBL] [Abstract][Full Text] [Related]
11. Preparation and study of new poly-8-hydroxyquinoline chelators for an anti-Alzheimer strategy.
Deraeve C; Boldron C; Maraval A; Mazarguil H; Gornitzka H; Vendier L; Pitié M; Meunier B
Chemistry; 2008; 14(2):682-96. PubMed ID: 17969218
[TBL] [Abstract][Full Text] [Related]
12. Regulation of copper and iron homeostasis by metal chelators: a possible chemotherapy for Alzheimer's disease.
Robert A; Liu Y; Nguyen M; Meunier B
Acc Chem Res; 2015 May; 48(5):1332-9. PubMed ID: 25946460
[TBL] [Abstract][Full Text] [Related]
13. Metals ions and neurodegeneration.
Molina-Holgado F; Hider RC; Gaeta A; Williams R; Francis P
Biometals; 2007 Jun; 20(3-4):639-54. PubMed ID: 17294125
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of peptidic metal chelators for neuroprotection in neurodegenerative diseases.
Zheng H; Youdim MB; Weiner LM; Fridkin M
J Pept Res; 2005 Oct; 66(4):190-203. PubMed ID: 16138857
[TBL] [Abstract][Full Text] [Related]
15. Hydroxyquinoline based binders: promising ligands for chelatotherapy?
Budimir A; Humbert N; Elhabiri M; Osinska I; Biruš M; Albrecht-Gary AM
J Inorg Biochem; 2011 Mar; 105(3):490-6. PubMed ID: 20926137
[TBL] [Abstract][Full Text] [Related]
16. Structural diversity and supramolecular aggregation in calcium, strontium, and barium salicylates incorporating 1,10-phenanthroline and 4,4'-bipyridine: probing the softer side of group 2 metal ions with pyridinic ligands.
Murugavel R; Korah R
Inorg Chem; 2007 Dec; 46(26):11048-62. PubMed ID: 18047324
[TBL] [Abstract][Full Text] [Related]
17. "Click-to-chelate": design and incorporation of triazole-containing metal-chelating systems into biomolecules of diagnostic and therapeutic interest.
Struthers H; Spingler B; Mindt TL; Schibli R
Chemistry; 2008; 14(20):6173-83. PubMed ID: 18494020
[TBL] [Abstract][Full Text] [Related]
18. Thermodynamic remarks on chelating ligands for aluminium related diseases.
Crisponi G; Nurchi VM
J Inorg Biochem; 2011 Nov; 105(11):1518-22. PubMed ID: 22099162
[TBL] [Abstract][Full Text] [Related]
19. Click-connected ligand scaffolds: macrocyclic chelates for asymmetric hydrogenation.
Zhang Q; Takacs JM
Org Lett; 2008 Feb; 10(4):545-8. PubMed ID: 18189407
[TBL] [Abstract][Full Text] [Related]
20. Multidentate terephthalamidate and hydroxypyridonate ligands: towards new orally active chelators.
Abergel RJ; Raymond KN
Hemoglobin; 2011; 35(3):276-90. PubMed ID: 21599440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
